98%
921
2 minutes
20
Eczema (atopic dermatitis, AD) is a skin disease characterized by skin barrier dysfunction due to various factors, including genetics, immune system abnormalities, and environmental triggers. Application of emollients and topical drugs such as corticosteroids and calcineurin inhibitors form the mainstay of treatments for this challenging condition. This review aims to summarize the recent advances made in phytochemical-based topical applications to treat AD and the different carriers that are being used. In this review, the clinical efficacy of several plant extracts and bioactive phytochemical compounds in treating AD are discussed. The anti-atopic effects of the herbs are evident through improvements in the Scoring Atopic Dermatitis (SCORAD) index, reduced epidermal thickness, decreased transepidermal water loss, and alleviated itching and dryness in individuals affected by AD as well as in AD mouse models. Histopathological studies and serum analyses conducted in AD mouse models demonstrated a reduction in key inflammatory factors, including thymic stromal lymphopoietin (TSLP), serum immunoglobulin E (IgE), and interleukins (IL). Additionally, there was an observed upregulation of the filaggrin (FLG) gene, which regulates the proteins constituting the stratum corneum, the outermost layer of the epidermis. Carriers play a crucial role in topical drug applications, influencing dose delivery, retention, and bioavailability. This discussion delves into the efficacy of various nanocarriers, including liposomes, ethosomes, nanoemulsions, micelles, nanocrystals, solid-lipid nanoparticles, and polymeric nanoparticles. Consequently, the potential long-term side effects such as atrophy, eruptions, lymphoma, pain, and allergic reactions that are associated with current topical treatments, including emollients, topical corticosteroids, topical calcineurin inhibitors, and crisaborole, can potentially be mitigated through the use of phytochemical-based natural topical treatments.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11120771 | PMC |
http://dx.doi.org/10.3390/ijms25105375 | DOI Listing |
Pharmaceutics
August 2025
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Phytochemicals exhibit a broad spectrum of pharmacological activities, including significant anticancer potential. However, their clinical translation is often hampered by poor aqueous solubility, low bioavailability, and chemical instability. Lipid-based nanocarriers, especially solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), have proven to be effective strategies for addressing these challenges.
View Article and Find Full Text PDFPhytomedicine
September 2025
Department of Molecular and Life Science, Hanyang University, Ansan 15588, Republic of Korea; Department of Medicinal and Life Science, Hanyang University, Ansan 15588, Republic of Korea; Department of Molecular Medicine, School of Biopharmaceutical Convergence, Ansan 15588, Republic of Korea. Elect
Background: Phytochemicals exhibit multi-target therapeutic potential with low toxicity, but their clinical translation is limited by poor bioavailability, unclear mechanisms, inadequate models, and structural instability. Addressing these barriers requires integrated strategies that preserve structure-function integrity and improve translational fidelity.
Purpose: This review identifies key translational barriers of phytochemicals and proposes integrated, structure-informed strategies combining delivery systems, mechanistic insights, and advanced models to preserve structure-function integrity and enable their application in precision medicine.
Recent Adv Inflamm Allergy Drug Discov
July 2025
Department of Pharmaceutics, Columbia Institute of Pharmacy, Raipur, India.
The study aims to investigate and assess the effectiveness of current novel techniques for the preparation of an efficient nanocarrier system in resolving the drawbacks associated with the delivery of herbal bioactives to treat rheumatoid arthritis. Systematic utilization of various search engines like Science Direct, Pubmed, Shodhganga, Google Scholar, and Google Patent databases based on various sets of key phrases has been performed. All the findings from these data have been studied and briefed based on their relevant and irrelevant information.
View Article and Find Full Text PDFSemin Oncol
October 2025
Phytotherapy Lab, Endocrinology Unit, Department of Medicine (DIMED), University of Padova, Padova, Italy; Accademia Italiana di Fitoterapia, Brescia, Italy.
Natural compounds with multitargeted actions are gaining prominence in oncology for their potential to complement and transcend the limitations of conventional therapies. Among them, baicalein and baicalin, two flavonoids primarily isolated from Scutellaria baicalensis, have attracted attention for their broad-spectrum anticancer properties. This review synthesizes current evidence from cellular systems, animal models, and early-phase clinical studies, exploring their pharmacological potential and translational relevance.
View Article and Find Full Text PDFMolecules
April 2025
Centre of Nutrition and Food Science, Queensland Alliance of Agriculture and Food Innovation (QAAFI), The University of Queensland, Brisbane, QLD 4072, Australia.
Mango ( L.) cultivars display a wide range of ripe flesh colours, from deep-orange to pale-yellow, largely linked to differences in carotenoid profiles. This study examined the relationship between carotenoid profile and flesh colour across 25 mango cultivars.
View Article and Find Full Text PDF